Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

MD Medical Group Investments Plc: MD Medical Group announces the Annual General Meeting


MD Medical Group Investments Plc (MDMG)
MD Medical Group Investments Plc: MD Medical Group announces the Annual General Meeting

03-Apr-2023 / 10:00 MSK


 MD Medical Group announces THE ANNUAL GENERAL MEETING

3 April 2023 – MD Medical Group Investments Plc (“MD Medical Group,” “MDMG,” the “Group” or the “Company” – LSE and MOEX: MDMG), a leading Russian private healthcare provider,  announces that at a meeting on 31 March 2023 the Board of Directors of MD Medical Group Investments Plc called an Annual General Meeting of shareholders to be held on 26 April 2023 at 10:00 am (Moscow time) in Lapino Hospital, Lapino 111, Odintsovsky District, Moscow Region, the Russian Federation, to consider and, if thought fit, pass resolutions 1 to 5 which will be proposed as ordinary resolutions, being items of ordinary business:

  1. To receive and consider the consolidated financial statements of the Company for the financial year ended 31 December 2022, together with the reports of the directors and independent auditors
  2. To appoint GAC Auditors Ltd as the auditor of the separate financial statements of the Company for 2023 and Joint Stock Company KEPT as the auditor of the interim condensed consolidated financial statements and annual consolidated financial statements of the Company for 2023, to hold office until the conclusion of the next annual general meeting of the Company and to authorize the Board of Directors to determine the remuneration of the auditors
  3. To approve Mr. Sergey Kalugin as an independent non-executive director of the Company with an annual remuneration of RUB 4,000,000 to hold such office until the conclusion of the annual general meeting of the Company to be held in 2024
  4. To appoint Ms. Tatiana Lukina as an independent non-executive director of the Company with an annual gross remuneration of RUB 944,000, to hold such office until the conclusion of the annual general meeting of the Company to be held in 2024
  5. To appoint Mr. Vitaly Ustimenko as an independent non-executive director of the Company with an annual gross remuneration of RUB 944,000, to hold such office until the conclusion of the annual general meeting of the Company to be held in 2024

The record date to participate the Annual General Meeting of shareholders shall be 31 March 2023.

 

***

For further information please contact:

Investors

Battalova Renata

Investor Relations Director

Tel.: +7 917 294 28 82

[email protected]

About MD Medical Group

MD Medical Group is a leading provider in the Russian private healthcare service market. The Company manages 53 modern healthcare facilities, including 10 hospitals and 43 out-patient clinics in 26 regions of Russia. In 2022, MD Medical Group's revenue amounted to RUB 25.2 bln while EBITDA amounted to RUB 7.9 bln. The Company's GDRs are traded on London Stock Exchange (LSE: MDMG) and Moscow Exchange (MOEX: MDMG).



Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


ISIN: US55279C2008
Category Code: NOA
TIDM: MDMG
LEI Code: 213800XKI6VHY4JBS612
Sequence No.: 234274
EQS News ID: 1598957

 
End of Announcement EQS News Service

fncls.ssp?fn=show_t_gif&application_id=1598957&application_name=news&site_id=sharewise

MD Medical Group Investments GDR Stock

€5.00
-13.040%
MD Medical Group Investments GDR took a tumble today and lost -€0.750 (-13.040%).

Like: 0
Share
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments